Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β,186. This growth factor maybe derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of extracellular matrix proteins by dermal fibroblasts.
This report contains market size and forecasts of Cutaneous Fibrosis Drugs in Global, including the following market information:
Global Cutaneous Fibrosis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cutaneous Fibrosis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cutaneous Fibrosis Drugs include Pfizer, Novartis, Sanofi, Merck, Roche, GlaxoSmithKline, Bayer, Boehringer Ingelheim and Horizon Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cutaneous Fibrosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cutaneous Fibrosis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cutaneous Fibrosis Drugs Market Segment Percentages, by Type, 2021 (%)
Corticosteroids
Anti-Fibrotic Drugs
Immunoglobulins
Global Cutaneous Fibrosis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cutaneous Fibrosis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Global Cutaneous Fibrosis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cutaneous Fibrosis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cutaneous Fibrosis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cutaneous Fibrosis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Sanofi
Merck
Roche
GlaxoSmithKline
Bayer
Boehringer Ingelheim
Horizon Pharma
Bristol-Myers Squibb